SK Biopharmaceuticals Co. Ltd. has identified GTPase KRAS (G12D mutant) inhibitors reported to be useful for the treatment of cancer.

Ildong Pharmaceutical Co. Ltd. has described GTPase KRAS inhibitors reported to be useful for the treatment of cancer.

Sunshine Lake Pharma Co Ltd. has identified pyrimidopyridine compounds acting as GTPase KRAS (G12D mutant) inhibitors reported to be useful for the treatment of cancer.

Amgen Inc. has synthesized GTPase KRAS (G12C mutant) inhibitors reported to be useful for the treatment of cancer.

Ildong Pharmaceutical Co. Ltd. has identified novel tetraheterocycle compounds acting as GTPase KRAS inhibitors reported to be useful for the treatment of cancer.

Chengdu Origiant Pharmaceutical Co. Ltd. has described GTPase KRAS (G12D mutant) inhibitors reported to be useful for the treatment of cancer.

Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have identified pyrimidine-containing polycyclic compounds acting as GTPase KRAS (G12D mutant) inhibitors reported to be useful for the treatment of cancer.

Merck Sharp & Dohme LLC has disclosed compounds acting as GTPase KRAS inhibitors reported to be useful for the treatment of cancer.

University of California Oakland has divulged GTPase KRAS (G12R mutant) inhibitors reported to be useful for the treatment of cancer.

Jacobio Pharmaceuticals Co. Ltd. has described GTPase KRAS (mutant) inhibitors reported to be useful for the treatment of cancer.